# Long-term Follow-up of Measles Antibodies

> **NCT00168571** · PHASE4 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 1960 (—)

## Conditions studied

- Measles

## Interventions

- **BIOLOGICAL:** Measles vaccine

## Key facts

- **NCT ID:** NCT00168571
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 1960 (—)
- **Last updated:** 2011-09-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168571, "Long-term Follow-up of Measles Antibodies". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00168571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*